Suan, Switzel Jean .
HRN: 00-95-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/13/2023
IVT
1.5gms
Q 8 Hrs
NKA
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes